End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Mar. 18 | Pharmaceutical Groups Idorsia, Viatris Finalize Collaboration to Develop Selatogrel, Cenerimod | MT |
Mar. 12 | Insud Pharma S.L.U. acquired Women Healthcare business of Viatris Inc.. | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Brands
63.7
%
| 9,890 | 60.8 % | 9,801 | 63.7 % | -0.90% |
Generics
36.3
%
| 5,015 | 30.8 % | 5,588 | 36.3 % | +11.42% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Developed Markets
37.0
%
| 5,844 | 35.9 % | 5,700 | 37.0 % | -2.46% |
United States
23.1
%
| 3,947 | 24.3 % | 3,552 | 23.1 % | -10.00% |
Emerging Markets
16.6
%
| 2,637 | 16.2 % | 2,552 | 16.6 % | -3.24% |
China
12.3
%
| 1,951 | 12.0 % | 1,889 | 12.3 % | -3.19% |
Japan, Australia and New Zealand
9.3
%
| 1,634 | 10.0 % | 1,425 | 9.3 % | -12.81% |
Greater China
1.8
%
| 250 | 1.5 % | 271 | 1.8 % | +8.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Scott Smith
CEO | Chief Executive Officer | 61 | 22-12-28 |
Rajiv Malik
PSD | President | 63 | 20-11-15 |
David Bayles
CMP | Compliance Officer | - | 20-11-15 |
Chief Tech/Sci/R&D Officer | - | - | |
Philippe Martin
CTO | Chief Tech/Sci/R&D Officer | - | Dec. 14 |
Chief Operating Officer | - | 20-11-15 | |
Abhijit Barve
CTO | Chief Tech/Sci/R&D Officer | - | - |
Bill Szablewski
IRO | Public Communications Contact | - | 20-11-15 |
Investor Relations Contact | - | 20-10-31 | |
Arun Narayan
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Melina Higgins
CHM | Chairman | 56 | 20-11-15 |
Mark Parrish
BRD | Director/Board Member | 68 | 20-11-15 |
Harry Korman
BRD | Director/Board Member | 66 | 20-11-15 |
James Kilts
BRD | Director/Board Member | 76 | 20-11-15 |
Elisha Finney
BRD | Director/Board Member | 62 | 22-12-28 |
Robert Coury
BRD | Director/Board Member | 63 | 20-11-15 |
Rajiv Malik
PSD | President | 63 | 20-11-15 |
Scott Smith
CEO | Chief Executive Officer | 61 | 22-12-28 |
JoEllen Dillon
BRD | Director/Board Member | 60 | 20-11-15 |
Richard Mark
BRD | Director/Board Member | 70 | 20-11-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,208,808,670 | 1,183,768,927 ( 97.93 %) | 21,239,521 ( 1.757 %) | 97.93 % |
Company contact information
Viatris, Inc.
Robert J. Coury Global Center 1000 Mylan Boulevard
15317, Canonsburg
+724 514 1800
http://www.viatris.comGroup companies
Name | Category and Sector |
---|---|
Utah Acquisition Sub, Inc.
| |
Biosimilars Newco Ltd.
Biosimilars Newco Ltd. Chemicals: SpecialtyProcess Industries Part of Viatris, Inc., Biosimilars Newco Ltd. is a British company that manufactures organic chemicals. The private company is located in UK. |
Chemicals: Specialty
|
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+30.83% | 687B | |
+30.96% | 595B | |
+0.01% | 378B | |
+15.18% | 316B | |
+11.39% | 308B | |
+0.78% | 211B | |
-6.09% | 208B | |
-2.92% | 203B | |
-3.72% | 157B |
- Stock
- Equities
- Stock Viatris Inc.
- Stock Mylan Inc - Nasdaq
- Company Mylan Inc